Zacks Investment Research on MSN21h
ABT Stock to Gain From Early CE Mark Approval of Volt PFA System
Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...
Abbott joins AFib-treating race with tech that may skip general anesthesia
Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...